Linking Ubiquitin Research to Drug Discovery

CLS2

Ubiquigent Limited enables and supports protein degradation focused drug discovery via modulation and exploitation of the ubiquitin system.

Our chemistry and biology platforms allow us to design and develop novel compounds as part of strategic partnerships.  In parallel we also provide access to our platforms and capabilities for the evaluation of our partners’ compounds.

Ubiquigent provides support to programmes at all stages from the provision of assay development and compound profiling Drug Discovery Services and Research Tools, through to larger Collaborative Drug Discovery Programmes for the delivery of hit and lead compounds.